Ann: Ceasing to be a substantial holder, page-6

Thanks for the lesson on technical analysis Pennas, but what was your conclusion - is BNO a buy or a sell?

Looking at a basic chart suggests that momentum has dissipated and the stock appears to be "rolling over".

So, it looks pretty sick to me and there seems to be no progress on the oncology sales process - nor have we had any update on completion of dosing for the lucky punters trialing BNC 210.

The company needs to get hold of the book "Investor relations 101" because they are clearly trying to operate on their own gut feelings and hunches when it comes to maintaining investor/shareholder interest and a fully informed market!

Sheesh......little wonder Private Portfolio Partners have taken some money off the table!

Cheers